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Ethnopharmacological  relevance:  Brassica  oleracea  var.  acephala  DC has  been  extensively  used  in  Brazilian
traditional  medicine  to treat  gastric  ulcer.
Aim of the  study:  This  study  was  conducted  to  evaluate  the  antiulcerogenic  property  of  hydroalcoholic
extract  obtained  from  the leaves  of Brassica  oleracea.
Materials  and methods:  Antiulcer  assays  were  performed  using  the  protocol  of  ulcer  induced  by
ethanol/HCl,  and  non-steroidal  anti-inﬂammatory  drugs  (NSAIDs).  Parameters  of  gastric  secretion  (vol-
ume, pH  and  [H+]) were  determined  by  the  pylorus  ligation  model  and  mucus  in  gastric  contents.
Results:  In  the  ethanol-induced  ulcer  model,  we  observed  a  signiﬁcant  reduction  in all  the  parameters
analyzed,  obtaining  curative  ratios  of  58.8 ±  11.5,  86.2  ± 12.2  and  42.8  ±  6.6%  for  the  groups  treated  with
50 and  100  mg/kg  of  extract  and  omeprazole  (30 mg/kg),  respectively.  The  dose of  25  mg/kg of  hydroal-
coholic  extract  of Brassica  oleracea  showed  no  signiﬁcant  results.  In  the  indomethacin-induced  ulcer,  the
percentages  of  ulcer  inhibition  were  64.3  ±  9.9,  66.4 ±  12.3  and  81.2  ± 7.5%  for the  groups  treated  with
50  and  100  mg/kg  extract  and  positive  control  (cimetidine,  100  mg/kg),  respectively.  The  results  showed
a signiﬁcant  increase  in  pH and  mucus  production  in  the  groups  treated  with  Brassica  oleracea  when
compared  with  the  control  group.  No  sign  of toxicity  was  observed  in  the  acute  toxicity  study.
Conclusions:  The  results  of  the  present  study  show  that hydroalcoholic  extract  of Brassica  oleracea  dis-
plays  antiulcer  activity,  as demonstrated  by the  signiﬁcant  inhibition  of  ulcer  formation  induced  using
different  models.  The  data  suggest  that  the  effectiveness  of  the  extract  is based  on  its ability  to  stimulate
the  synthesis  of mucus,  increase  pH  and  decrease  H+ ions  in  the stomach.  This  work  corroborates  the
ethnopharmacology  use  of  Brassica  oleracea  preparations,  contributing  to  its  pharmacological  validation
by suggesting  that  preparations  obtained  from  Brassica  oleracea  could  be  used for  the  development  of
new  phytopharmaceuticals  for the  treatment  of  gastric  ulcer.
 . Introduction
Gastric ulcer is a chronic disease affecting millions of people
orldwide (Klein-Júnior et al., 2010). The pathology is the result of
n imbalance between the protective agents (such as the mucosal
arrier, mucus secretion and cell regeneration) and aggressors of
he gastric mucosa (such as acid–pepsin secretion) linked to the
rocess of digestion and other factors, such as excess alcohol con-
umption, chronic treatment of non-steroidal anti-inﬂammatories,
tress, and infection caused by Helicobacter pylori (Barocelli et al.,
997; Tulassay and Hersnzényi, 2010; Oliveira et al., 2011).
Currently, the treatment is performed mainly with antacids
nd histamine receptor antagonists-2 (H2-Ras) and proton pump
∗ Corresponding author. Tel.: +55 4733417901.
E-mail addresses: sfaloni@bol.com.br, faloni@univali.br (S.F.d. Andrade).
378-8741 © 2011 Elsevier Ireland Ltd. 
oi:10.1016/j.jep.2011.09.046
Open access under the Elsevier OA license. © 2011 Elsevier Ireland Ltd. 
inhibitors. However, prolonged use of H2-Ras and proton pump
inhibitors can cause serious side effects such as hypersensitivity,
arrhythmia, impotence, gynecomastia and hematopoietic disor-
ders (Malfertheiner et al., 2009; Sheen and Triadaﬁlopoulos, 2011).
Therefore, there is a need to search for new, more effective and safer
treatments, with less side effects. In this context, plant extracts are
among the most promising substances in the search for new ther-
apies for the treatment of gastric ulcer (Bighetti et al., 2005; Jainu
and Devi, 2006; Santin et al., 2010).
The family Brassicaceae has approximately 350 genera, divided
into 13 tribes, and has about 3200 species (Kowalsky et al., 1994;
Joly, 1998). Brassica oleracea var. acephala DC, which belongs to this
family, is popularly known in Brazil as “couve” (Lima et al., 2007)
Open access under the Elsevier OA license.and in countries of English language as “kale” (Joly, 1998). Several
studies have been conducted with this species, showing antimicro-
bial activity against Gram-positive bacteria, and strong antioxidant
activity (Sousa et al., 2008). There are several Brazilian reports
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ndicating that the juice prepared by the population from the leaves
f Brassica oleracea, ingested during fasting, leads to relief of symp-
oms of gastric ulcers and also some other diseases such as diabetes
ellitus, cirrhosis and rheumatism (Moreira et al., 2002; Silva et al.,
006; Miron et al., 2006; Lima et al., 2007; Santos and Lima, 2008).
lso, in a quick Internet search using the terms “úlcera” (Portuguese
or ulcer) and “couve” are found more than 35.000 websites relat-
ng to the popular use of this vegetable for the treatment of gastric
lcers. Moreover, in an ethnopharmacological study conducted by
ilva et al. (2006),  it was found that Brassica oleracea is the plant
hat is most commonly used by the Brazilian population, for the
reatment of gastritis and gastric ulcers.
Studies also point to the presence of phenolic acids, which
howed antifungal and antibacterial activity (Ayaz et al., 2008).
his plant also contains some ﬂavonoids, especially quercetin and
aempferol, mainly in glycosidic form. Flavonoids are secondary
etabolites that are widely distributed in nature and have several
iological activities, including gastroprotector potential (Martin
t al., 1998).
Akhtar and Munir (1989) evaluated the powder obtained from
ried leaves of Brassica oleracea in the aspirin-induced ulcer model.
n this study, an increase in gastric protection was observed. How-
ver, the authors used only one model to evaluate the antiulcer
ctivity, without studying some other models that could enable
 better understanding of the gastroprotective mechanisms. The
resent study was therefore performed, to evaluate the antiulcer
ctivity of the hydroalcoholic extract obtained from the leaves of
rassica oleracea, a medicinal plant widely used by the population
or the treatment of gastric ulcers.
. Materials and methods
.1. Plant material
The leaves of Brassica oleracea were collected in Rio das Antas,
n the state of Santa Catarina, Brazil, in September 2008 (Latitude
6◦57′31.96 “N, longitude 51◦0′23.76” W)  and identiﬁed by Dr.
maury Antônio Silva Junior. A voucher specimen was deposited at
he Barbosa Rodrigues Herbarium (Itajaí, SC) under number 52747.
ir-dried material (700 g) was cut into small pieces and macerated
ith aqueous ethanol mixture 50% (v/v) at room temperature for 10
ays. The macerate was ﬁltered and the solvent removed by rota-
ory evaporator under reduced pressure, yielding 306.47 g (43.78%)
f crude hydroalcoholic extract.
.2. Preliminary phytochemical analysis of extract
Thin layer chromatography (TLC) was used to evaluate the
hemical composition of Brassica oleracea extract. The follow-
ng solvent system was used: hexane:ethyl acetate (7:3) and
hloroform:methanol (7:3) and revealed with reagents speciﬁc
hromophores, anisaldehyde for terpenoids and ferric chloride for
henolic compounds. Different patterns solutions of terpenes and
avonoids were used for the purposes of comparison.
.3. Drugs, reagents and solvents
Indomethacin, cimetidine, omeprazole and carbenoxolone were
urchased from Sigma–Aldrich (St. Louis, MD,  USA). All the other
eagents and solvents used were of analytical grade.
.4. AnimalsWistar rats female (250–350 g) and Swiss mice male (25–35 g)
ere provided by the Central Animal House of the Universidade
o Vale do Itajaí (UNIVALI), Itajaí, SC. The animals were housed inmacology 138 (2011) 503– 507
groups of six, in standard cages, at room temperature (25 ± 3 ◦C),
with 12 h dark/12 h light cycles, and supplemented with food and
water ad libitum. They were transferred to the laboratory twelve
hours prior to the experiments and given only water ad libitum.
In all the experiments, the animals were kept in cages with raised
ﬂoors of wide mesh, to prevent coprophagy. The animals used in
the present study were housed and cared for in accordance with
the Federal Government legislation on animal care. The experi-
ments were also authorized by the Ethical Committee for Animal
Care (number 0369/09a) of the Universidade do Vale do Itajaí, Itajaí,
Santa Catarina, Brazil.
2.5. Evaluation of antiulcer activity
2.5.1. Doses
This plant is traditionally taken orally, as a juice prepared with
5.0 g of leaves in approximately 200 ml  of water, which is drunk
once a day. Thus, for a person weighing 80 kg, this administration
represents an intake of approximately 62.5 g/kg/day. Based on this
traditional preparation and use, the extract was administered by
the oral route at 25, 50 and 100 mg/kg.
2.5.2. Ethanol/HCl-induced ulcer
The experiment was  performed according to the method
described by Mizui and Doteuchi (1983).  After 12 h of fasting, the
mice were randomly divided into ﬁve groups of six animals each.
The ﬁrst group was given 0.5 ml  of vehicle (1% Tween 80 aque-
ous solution), and the second group was  treated with omeprazole
(30 mg/kg). The remaining groups received 25, 50 and 100 mg/kg of
hydroalcoholic extract of Brassica oleracea. All the treatments were
administered orally. One hour after treatment, all the mice received
0.5 ml  of a 0.3 mol/l HCl/60% ethanol solution (ethanol/HCl) to
induce gastric ulcer. Another hour later, the animals were sacri-
ﬁced by cervical dislocation, and the stomachs removed and opened
along the greater curvature. The stomachs were gently rinsed with
water to remove the gastric contents and blood clots, for sub-
sequent scanning. The images obtained were analyzed using the
parameters described in the section on stomach analysis.
2.5.3. Nonsteroidal anti-inﬂammatory drug (NSAID)-induced
ulcer
The experiment was  performed according to the method
described by Rainsford and Whitehouse (1980),  with a few mod-
iﬁcations. After 12 h of fasting, the mice were randomly divided
into ﬁve groups of six animals each. The ﬁrst group was given
0.5 ml  of vehicle (1% Tween 80 aqueous solution), and the sec-
ond group was  treated with cimetidine (100 mg/kg). The remaining
four groups received 25, 50 and 100 mg/kg of hydroalcoholic
extract of Brassica oleracea. All the treatments were administered
orally. One hour after treatment, all the mice received a combina-
tion of indomethacin (100 mg/kg, p.o.) and bethanechol (5 mg/kg,
i.p.) to induce gastric ulcer. Twelve hours after treatment with
indomethacin and bethanechol, the animals were sacriﬁced by cer-
vical dislocation. The stomachs were removed and opened along
the greater curvature, then gently rinsed with water to remove
the gastric contents and blood clots, for subsequent scanning. The
images obtained were analyzed using the parameters described in
the section on stomach analysis.
2.5.4. Stomach analysis
The images obtained were analyzed using speciﬁc “EARP” soft-ware to measure each lesion point. The ulcers were classiﬁed as:
level I, ulcer area <1 mm2; level II, ulcer area 1–3 mm2; and level
III, ulcer area >3 mm2. The total area of lesion and the percentage of
lesion area in relation to total stomach area were determined. The
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Table 1
Effects of hydroalcoholic extract of Brassica oleracea and omeprazole on ethanol/HCl-induced ulcers in mice.
Treatment (p.o) Dose (mg/kg) Total area of lesion (mm2) % of lesion area Ulcer lesion index Curative ratio (%)
Control – 361.2 ± 51.3 27.2 ± 3.5 41.3 ± 3.7 –
Omeprazole 30 43.2 ±  10.4** 3.7 ± 1.0** 23.6 ± 2.7** 42.8 ± 6.6
Extract 25  145.2 ± 42.7** 12.9 ± 4.0** 34.8 ± 6.1 15.7 ± 14.9
50  25.9 ± 8.5** 0.2 ± 0.7** 17.0 ± 4.7** 58.8 ± 11.5
100 9.3 ± 8.3** 0.6 ± 1.0** 5.6 ± 5.0** 86.2 ± 12.2
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aesults as mean ± S.E.M. for six mice. Statistical comparison was performed using A
** p < 0.01 compared with the control group.
lcerative lesion index (ULI) was calculated as follows: 1x (num-
er of ulcers level I) + 2x (number of ulcers level II) + 3x (number
f ulcers level III). The curative ratio was determined as follows:
00 − (ULItreated × 100/ULIcontrol) (Zanatta et al., 2009; Santin et al.,
011).
.6. Determination of gastric secretion
The assay was performed using the method of Shay et al. (1945),
ith a few modiﬁcations. Mice were divided into groups (n = 6),
ccording to the treatment used, as previously described. After
4 h of fasting, the animals were anesthetized with ketamine and
ilazine 0.2 ml  solution i.p. The abdomen was  incised and the
ylorus ligated. Immediately after pylorus ligature, the hydroal-
oholic extract of Brassica oleracea was administered at doses of
5, 50 and 100 mg/kg. Cimetidine (100 mg/kg) was used as positive
ontrol, and 1 ml  of vehicle (1% Tween 80 aqueous solution) was
dministered as negative control. All the samples were adminis-
ered intraduodenally. Four hours later, the animals were sacriﬁced
y cervical dislocation; the abdomen was opened, and another lig-
ture placed at the esophageal end. The stomachs were removed
nd the gastric contents collected and centrifuged at 3000 rpm
8000 × g, 25 ◦C, 10 min). The amount of gastric-juice acid (ml) and
he pH values were determined. Total acid secretion in the gastric
esion was determined in the supernatant volume by titration to
H 7.0, using a 0.01 mol/l NaOH solution, and phenolphthalein as
ndicator.
.7. Determination of mucus in gastric content
This assay was performed according to the methodology
escribed previously by Sun et al. (1991) with a few modiﬁcations.
he mice were divided into groups (n = 6). After 24 h of fasting,
nder anesthesia, the abdomen was incised and the pylorus lig-
ted. Immediately after pylorus ligature, the hydroalcoholic extract
f Brassica oleracea (25, 50 and 100 mg/kg) were administered
ntraduodenally. Carbenoxolone (200 mg/kg) was used as positive
ontrol, and 0.5 ml  of vehicle (1% Tween 80 aqueous solution) was
dministered as negative control. The animals were killed 4 h after
he drug treatments. The stomach content was immersed in 10 ml
f 0.02% Alcian Blue 0.16 M sucrose/0.05 M sodium acetate solu-
ion, pH 5.8, and incubated for 24 h at 20 ◦C. Alcian Blue binding
xtract was centrifuged at 3000 × g for 10 min. The absorbency of
he supernatant was measured by spectrophotometry at 615 nm.
he free mucus in the gastric content was calculated from the
mount of Alcian Blue binding (mg/wt tissue (g)).
.8. Acute toxicity study
Acute toxicity study was performed as described in the “Guide-
ines for Testing of Chemicals – Acute Oral Toxicity – Fixed Dose
rocedure” (OECD 420, 2001). Five female rats were treated orally
ith a single dose of 2000 mg/kg of hydroalcoholic Brassica oler-
cea extract dissolved in 1% Tween 80 aqueous solution. After the
dministration, the animals were observed individually at least followed by the Dunnett’s test.
once during the ﬁrst 30 min  after dosing, periodically during the
ﬁrst 24 h (with special attention during the ﬁrst 4 h) and daily there-
after for a period of 14 days. The animals were observed once a
day, principally in relation to changes in skin and fur, eyes and
mucous membrane (nasal) and also autonomic changes (saliva-
tion, lacrimation, perspiration, piloerection, urinary volume, and
defecation) and alterations to the central nervous system (ptosis,
drowsiness, gait, tremors and convulsion). Food and water were
provided throughout the experiment.
2.9. Statistical analysis
The data are reported as mean ± standard error of the mean
(SEM) and were compared using one-way analysis of variance
(ANOVA), followed by the Dunnett’s pair wise test, with p val-
ues < 0.05 considered signiﬁcant.
3. Results and discussion
The treatment of ulcers is based on the use of antacids, anti-
cholinergics, proton pump inhibitors and H2-receptor antagonists.
In cases of infection by H. pylori, the use of antibiotics is added,
to eradicate the bacteria (Naik et al., 2007). However, the treat-
ments currently available present side effects, often leading to
non-adhesion to the treatment (Bighetti et al., 2005; Santin et al.,
2011). For these reasons, the search for new drugs is very relevant,
and medicinal plants and natural products play a key role in these
studies, since many extracts and isolated compounds have shown
promising results in the treatment and prevention of gastric ulcers,
inﬂammation and pain (Sannomiya et al., 2005; Massignani et al.,
2009).
To evaluate the gastroprotective effect of the extract of Bras-
sica oleracea, the model of acute ulcer induced by ethanol/HCl was
ﬁrst performed. Ethanol is considered one of the agents that most
induces gastric ulcers. The effects of ethanol on the gastric mucosa
may  be associated with the formation of reactive oxygen species,
which cause an imbalance between oxidant and antioxidant cel-
lular process, resulting in severe damage to the vascular plexus.
This leads to rupture of blood vessels, which can result in hem-
orrhage and necrosis and retro diffusion of hydrogen ions, causing
exfoliation of the epithelial cells, disrupting the protective mucosal
barrier and altering membrane permeability (Lewis and Hanson,
1991; Sikiric et al., 1997). The HCl present in this model acceler-
ates the process of gastric ulcerogenesis and intensiﬁes the lesions,
impairing the mucosal protection against chemical agents (Sun
et al., 1991).
In this model, we  found that treatment with hydroalcoholic
extract of Brassica oleracea (50 and 100 mg/kg) and omeprazole
(30 mg/kg) signiﬁcantly reduced the lesion index, the total injured
area and the percentage of injured area, compared with the con-
trol group (p < 0.01) (Table 1). The curative ratio obtained was
58.8 ± 11.5, 86.2 ± 12.2 and 42.8 ± 6.6% for the groups treated with
50 and 100 mg/kg of extract and omeprazole (positive control,
30 mg/kg), respectively. The dose of 25 mg/kg of extract showed
no signiﬁcant results in all the parameters evaluated. These results
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Table 2
Effects of hydroalcoholic extract of Brassica oleracea and cimetidine on non-steroidal anti-inﬂammatory drug-induced ulcer in mice.
Treatment (p.o) Dose (mg/kg) Total area of lesion (mm2) % of lesion area Ulcer lesion index Curative ratio (%)
Control – 11.1 ± 1.0 3.8 ± 0.5 25.8 ± 1.8 –
Cimetidine 100 1.9 ± 0.7** 0.4 ± 0.1** 4.8 ± 1.5** 81.2 ± 7.5
Extract 25  6.8 ± 2.6 2.5 ± 0.4 22.0 ± 1.9 14.5 ± 12.4
50  4.2 ± 0.8* 1.1 ± 0.4** 9.2 ± 2.4** 64.3 ± 9.9
100  4.1 ± 0.7** 0.4 ± 0.1** 8.6 ± 2.4** 66.4 ± 12.3
Results as mean ± S.E.M. for six mice. Statistical comparison was performed using ANOVA followed by the Dunnett’s test.
* p < 0.05 compared with the control group.
** p < 0.01 compared with the control group.
Table 3
Effects of Brassica oleracea extract and cimetidine, administered intraduodenally, on the biochemical parameters of gastric juice obtained from pylorus-ligature in mice.
Treatment (p.o) Dose (mg/kg) Volume (ml) pH [H+] (mEq/I/4h)
Control – 0.54 ± 0.09 3.15 ± 0.21 99.15 ± 12.32
Cimetidine 100 0.35 ± 0.02* 4.97 ± 0.51** 34.00 ± 4.30**
Extract 25 0.49 ± 0.04 4.21 ± 0.51 51.36 ± 5.21**
50 0.40 ± 0.05 4.16 ± 0.16* 46.62 ± 0.52**
100 0.37 ± 0.06* 4.27 ± 0.32* 44.16 ± 3.60**
Results as mean ± S.E.M. for six mice. Statistical comparison was performed using ANOVA followed by the Dunnett’s test.
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Table 4
Effects of Brassica oleracea extract and carbenoxolone on Alcian Blue binding to free
gastric mucus from pylorus ligature in mice.
Treatment (p.o) Dose (mg/kg) Alcian Blue bound
(mg/wt tissue (g))
Control – 3.19 ± 0.62
Carbenoxolone 200 4.30 ± 0.32**
Indomethacin 100 1.44 ± 0.18
Extract 25 3.93 ± 0.12*
50 4.59 ± 0.31**
100 4.17 ± 0.25**
Results as mean ± S.E.M. for six mice. Statistical comparison was performed using
ANOVA followed by the Dunnett’s test.
* p < 0.05 compared with the control group.
** p < 0.01 compared with the control group.* p < 0.05 compared with the control group.
** p < 0.01 compared with the control group.
ndicate that the extract presents cytoprotective activity, since it
igniﬁcantly reduced the ethanol/HCl-induced ulcer.
Another protocol experimental used in this study was  NSAID-
nduced ulcer. Indomethacin and other NSAIDs act by inhibiting
rostaglandin synthesis through cyclooxygenase-1 block. Endoge-
ous prostaglandins are responsible for regulating the secretion of
ucus and bicarbonate, blood ﬂow and proliferation of epithelial
ells. Therefore, inhibition of prostaglandin synthesis weakens the
astric mucosal defenses, leading to the formation of lesions in the
astric epithelium (Cryer, 2000; Chan and Leung, 2002).
It was observed that the extract of Brassica oleracea (50 and
00 mg/kg) and the positive control (cimetidine 100 mg/kg) signif-
cantly reduced all the parameters evaluated, compared with the
ontrol group (p < 0.05) in the indomethacin-induced ulcer model.
he dose of 25 mg/kg showed no signiﬁcant results. The percent-
ge of ulcer inhibition was 64.3 ± 9.9, 66.4 ± 12.3 and 81.2 ± 7.5%
or the groups treated with 50 and 100 mg/kg Brassica oleracea and
ositive control (cimetidine), respectively (Table 2). These results
uggest the possible involvement of prostaglandin production or
ucus in the antiulcer effect presented by the extract.
The interference of the extract on the parameters of gastric
ecretion was also evaluated using the pylorus ligature method.
his method is an important procedure that reveals possible
hanges of parameters relating to gastric secretion, e.g. gastric
ecretion volume, pH and H+ concentration. Following the adminis-
ration of Brassica oleracea extract, it was observed that the extract
t doses of 50 and 100 mg/kg, and the positive control (cimetidine,
00 mg/kg), caused increased gastric pH (p < 0.05) and decreased
he concentration of H+ ions (p < 0.01), compared with the control
roup (Table 3). These results suggest that the extract interfered
ith gastric acid secretion.
Considering that the gastric mucus is an important protective
actor for gastric mucosa, the Brassica oleracea extract was evalu-
ted in the model of determination of mucus in gastric contents. The
ucus coating is important because it protects the mucosa, as well
s repairing the damage caused to the gastric epithelium (Tulassay
nd Hersnzényi, 2010). When quantifying the free gastric mucus
n the tissue, it was veriﬁed that the extract in different doses, and
he positive control (carbenoxolone 200 mg/kg), caused a signif-
cant increase in mucus production compared with the negative
ontrol (Table 4).In addition, the data obtained in the test for acute toxicity sug-
gest that the toxic dose of Brassica oleracea extract (p.o.), in the test
of acute oral toxicity by a ﬁxed dose procedure, (OECD, 2001) was
higher than 2000 mg/kg.
Through phytochemical analysis of the Brassica oleracea extract,
the presence of ﬂavonoids, terpenes and sterols was demonstrated.
These secondary metabolite classes are related to the gastropro-
tector activity. Moreover, Troyer et al. (2001) and Moreno et al.
(2006) described a high quantity of glucosinolates. According to
Takeguchi et al. (1983),  glucosinolates are associated with antiul-
cer activity through in vitro inhibition of (H+–K+)-ATPase, reducing
the production of HCl. In view of this fact, it is suggested that the
gastroprotection elucidated by the extract of Brassica oleracea may
be related to the presence of ﬂavonoids, terpenes, sterols and glu-
cosinolates.
In conclusion, the results show that hydroalcoholic extract of
Brassica oleracea presents gastroprotective activity, as evidenced
by the different ulcer models assayed. The data suggest that the
effectiveness of the extract in prevention ulcer is based on its ability
to stimulate the synthesis of mucus, an important gastroprotective
factor, and also through an increase in pH and a decrease in H+ ions
in the stomach. The results obtained in this work demonstrate that
preparations obtained from Brassica oleracea could be used for the
development of a new phytopharmaceutical for the treatment of
ophar
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astric ulcer. However, further pharmacological investigations are
equired to delineate the mechanism(s) of action.
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